Document is current
Any future updates will be listed below
-
Authors
Kvitne, Kine Eide
Zuffa, Simone
Charron-Lamoureux, Vincent
Mohanty, Ipsita
Patan, Abubaker
Mannochio-Russo, Helena
Zemlin, Jasmine
Burnett, Lindsey A.
Zhang, Lisa S.
Cecala, Mia C.
Ersoz, Ceylan
Connelly, James A.
Halasa, Natasha
Nicholson, Maribeth
Dorrestein, Pieter C.
Tsunoda, Shirley M.
Markle, Janet
-
Funding
Funding for this research was provided by:
NICHD/NIH (5P30HD106451-03)
NICHD/NIH (5P30HD106451-03)
NICHD/NIH (5P30HD106451-03)
NICHD (P50HD106463)
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 16 December 2025
First Online: 31 December 2025
Competing interests
: S.M.T. receives research funding from Veloxis Pharmaceuticals. P.C.D. is an advisor and holds equity in Cybele, Sirenas, and BileOmix, and he is a scientific co-founder, advisor, holds equity and/or receives income from Ometa, Enveda, and Arome with prior approval by UC San Diego. P.C.D. consulted for DSM Animal Health in 2023. J.A.C. is an advisor for Pharming Pharmaceuticals. All other authors declare no conflicts of interest.
